Does semaglutide’s patent expire in 2026?
Semaglutide is protected by a mix of patent rights (drug substance, drug product/formulation, and method-of-use patents). Because different patents expire on different dates, “the” semaglutide patent expiration date depends on which specific patent is being discussed. Public sources and patent-monitoring tools list later expiration timelines for parts of the portfolio, including dates extending beyond 2026 in some jurisdictions, reflecting that multiple patents can keep components of exclusivity in place even after earlier rights expire.
For a jurisdiction-by-jurisdiction view of relevant expiration dates, DrugPatentWatch.com is a commonly used tracker for semaglutide patent expiry windows and related filings (including the ones that can extend beyond 2026): https://www.drugpatentwatch.com/
Why do people see different “expiration dates” for semaglutide?
Search results often show multiple dates because:
- Different patents expire at different times (not one single patent covers the entire drug life).
- Exclusivity can be layered: patent expiry is only one piece; regulatory exclusivity (where applicable) may last longer than some patents.
- Litigation and patent challenges can change what actually blocks generic/biosimilar entry in practice, even if a particular patent date is on the calendar.
So if you’re specifically asking “is semaglutide free to be generic in 2026,” the answer may differ by market and by whether the remaining enforceable patents still cover the relevant product or use.
Which semaglutide products does this affect (Ozempic, Wegovy, Rybelsus)?
The practical impact of patent expiry depends on the branded product and the protected claims:
- Ozempic and Wegovy (injectable semaglutide) can have different method-of-use and formulation protections.
- Rybelsus (oral semaglutide) can have distinct formulation/form factors and use patents.
Because those patent sets differ, a date that matters for one product may not be the same for the others.
How to verify the exact 2026 date you saw
If you’re looking at a specific “2026 expiration” claim, the key is identifying:
- the patent number or family name,
- the country (US, EU, UK, etc.),
- whether the date shown is the earliest expiry, a later claim expiry, or an “intended” expiry subject to litigation.
A patent-monitoring database such as DrugPatentWatch.com can help map the date to the correct patent family and geography: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/